Achieving 537.1 method requirements in a robust 10-minute method
Simon Roberts1, Craig Butt1, Dan Wright2, Stephen Somerville2, KC Hyland1, Chris Borton1
SCIEX, USA1, EQI, Columbia, SC, USA2
In order to protect the safety of drinking water and human health, the EPA releases methods for the detection of contaminants. The EPA method 537.1 describes the detection of selected per- and polyfluorinated alkyl substances in drinking water. Here a robust LC-MRM assay was developed using the QTRAP 4500 system for PFAS detection. Sensitive MDLs of 0.08-0.2 ng/L for all of 14 PFAS compounds in EPA method 537 were achieved, all of which meet or exceed the requirements of the US EPA’s UCMR3 list in a 10 minute run.
In the United States, EPA method 537.1 describes the sample preparation, reporting guidelines, and quality control for the analysis of a suite of 14 per- and polyfluorinated substances (PFAS) in drinking water. The EPA 537.1 method guidelines provide some flexibility in the liquid chromatography tandem mass spectrometry (LC-MS/MS) analysis. Within these guidelines, optimization of certain aspects of the method, such as column chemistry, chromatography, mobile phases, gradient profile, and MS/MS transitions, was performed. Sample preservation and preparation guidelines published in EPA 537.1 are prescriptive and were therefore closely followed.
Sample preparation: Sample preservation and preparation were performed according to the guidelines in EPA Method 537.1. Briefly, 1 g of Trizma was added to 250 mL polypropylene bottles. Bottles were pre-weighed to calculate the mass of sample collected. Surrogate standards were added to the sample container to achieve a final concentration of 2 ng/L in the 250 mL water sample.
The water samples were extracted using the following procedure with Phenomenex Strata-XL solid phase extraction cartridges (6 mL, 500 mg):
Chromatography: An Agilent 1200 binary pump was modified by replacing all clear fluoroethylene polymer (FEP) tubing with 1/8 in or 1/16 inch PEEK tubing. A delay column (Phenomenex Luna C18(2), 5µm, 30x2mm) was inserted between the gradient mixing chamber and the autosampler valve to retain contaminants from the eluents or pumps for an extra 1-2 min compared with target analytes eluting from the analytical column.
An Agilent 1200 autosampler injected 10 ul of each sample onto the analytical column (Phenomenex Gemini C18, 3µm, 50x2mm), which was heated to 40°C. Gradient separation was performed at a flow rate of 0.6 mL/min using the gradient shown in Table 2.
Mass spectrometry: Samples were ionized using negative mode electrospray using the QTRAP 4500 system at the source conditions shown in Table 3 and the Q1/Q3 masses, declustering potentials, and collision energies shown in the Supplementary information.1 Calibration was performed using an 8-point curve at concentrations of 50, 100, 200, 500, 1000, 2000, 5000, and 10000 ng/L and the concentrations of surrogates and internal standards was 1,000 ng/L in all final sample extracts, standards, method blanks, and quality control samples.
Data processing: Quantitation was performed using MultiQuant software 3.0.2 using 1.0 point Gaussian smoothing and 1/x weighted linear regression forced through the origin (as required by EPA 537.1). A concentration factor of 250 was applied to samples as a result of the concentration of 250 mL to the final 1 mL extract.
The initial calibration curve results achieved the following guidelines prescribed in EPA method 537.1:
To calculate method detection limits, 9 water samples were spiked with approximately 0.2 ng/L of each of the 14 PFAS compounds and analyzed following the full analytical protocol. The calculated MDLs shown Table 1 were calculated according to EPA 537.1 using the mean and standard deviation of the replicated spiked samples. The MDLs for all 14 compounds was below 0.2 ng/L, which highlights the excellent sensitivity of the method.
After 8 days of analyzing samples to calculate the MDL and other samples, the continuing calibrations still met the requirements of +/- 30% of expected calculated concentration for all 14 analytes, as shown in Table 4.
Blank samples showed very low responses and were always below the requirement of <1/3 of the MRL. Figure 4 shows the response of a method blank (red), which was a 250 mL water sample taken through the entire sample preparation protocol, and a reagent blank, which was 96% methanol and 4% water prepared in an autosampler vial. A small peak at 4.9 min in the chromatogram in Figure 4 shows presence of PFOA contamination presumably in the HPLC pumps or eluents and demonstrates the adequate separation from the quantitated analyte peak as a result of the delay column installment.
Proficiency testing (PT) samples were obtained from ERA and were analyzed along with the MDL replicates. The PT samples were diluted 10:1 with water and analyzed according to the procedures described in this note. The results of the 8 analytes present in PT CAT: 960 were all within +/- 18% of the assigned concentration of the PT study (Figure 5).
The HPLC method and MS/MS analysis for this validated 537 method were both fully compatible with an extended list of 25 analytes. However, the EPA method 537 sample preparation protocol relies on reverse phase, hydrophobic interactions for solid phase extraction (SPE) retention and, therefore, fails to adequately retain shorter chain PFCAs, including perfluorobutane carboxylate and perfluoropentane carboxylate. Modifying this sample preparation method by replacing Strata-XL with Strata-XL-AW (weak anion exchange) solid phase extraction tubes and altering the solvents used during extraction allows a longer, extended list to be analyzed using the same method.
Robust and reproducible results with quantitative accuracy and precision for calculated concentrations, asymmetry factor, and linearity were achieved in a single ten-minute LC-MS/MS acquisition on the SCIEX QTRAP 4500 system. Following stringent protocols for sample preparation and preservation defined by the EPA 537.1 method, method optimization steps were taken to continue to improve PFAS analysis workflow and quantitative performance.